NVS240719P125000
- 27.00
- 0.000.00%
Novartis AG Newsroom
Novartis AG (NOVN) Gets a Hold From Citi
Novartis Analyst Ratings
Jefferies Maintains Buy on Novartis, Raises Price Target to $122.5
Novartis AG (NOVN) Gets a Buy From Deutsche Numis
Buy Rating for Novartis AG on Strong Sales and Robust Operating Performance
Goldman Sachs Sticks to Their Buy Rating for Novartis AG (NOVN)
European pharmaceutical giant praised by Goldman Sachs: innovation is king, and three shares received a “buy” rating
Berenberg Raises Price Target on Novartis to CHF77 From CHF74, Maintains Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Carl Zeiss Meditec (GB:0DHC), Siemens Healthineers AG (OtherSEMHF) and Novartis AG (Six Swiss: CH:NOVN)
Novartis Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcidion Group Limited (ALC) and Novartis AG (Six Swiss: CH:NOVN)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Vertex Pharma Upgraded at Evercore on Alpine Immune Deal
Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN)
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN) and Biophytis SA (Frankfurt: DE:6XB)
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN) and Sigma Healthcare Ltd (Frankfurt: DE:S5YA)
BMO Capital Initiates Novartis at Market Perform Rating With $114 Price Target
BMO Capital Initiates Coverage On Novartis With Market Perform Rating, Announces Price Target of $114
Novartis Analyst Ratings